Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.8%

1 terminated/withdrawn out of 56 trials

Success Rate

95.2%

+8.7% vs industry average

Late-Stage Pipeline

13%

7 trials in Phase 3/4

Results Transparency

10%

2 of 20 completed trials have results

Key Signals

4 recruiting2 with results

Enrollment Performance

Analytics

Phase 2

17(37.8%)

N/A

14(31.1%)

Phase 1

4(8.9%)

Phase 4

4(8.9%)

Early Phase 1

3(6.7%)

Phase 3

3(6.7%)

45Total

Phase 2(17)

N/A(14)

Phase 1(4)

Phase 4(4)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (56)

Showing 20 of 56 trials

NCT07550881Phase 2Not Yet Recruiting

Intranasal Dexmedetomidine for Acute Anxiety State in Adults

Role: lead

NCT07544641Not ApplicableNot Yet Recruiting

Effect of Surgical Planning Prompts on Elective Surgery Acceptance Rate

Role: lead

NCT07162649Not ApplicableWithdrawn

Dexmedetomidine Nasal Spray for the Treatment of Panic Attacks in Adults

Role: lead

NCT07478419Completed

Machine Learning Prediction of 1-Year Refractive Error After SMILE

Role: lead

NCT07408661Completed

Application of Artificial Intelligence and Iron Metabolism Markers in Predicting ICU Outcomes for Critically Ill Cancer Patients

Role: lead

NCT07386639Completed

Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver Cancer

Role: lead

NCT07361237Phase 1Recruiting

A Phase l Clinical Study to Evalute the Safety,Tolerability,Pharmacokinetic Characteristics,and Preliminary Anti-tumor Efficacy of HJ-004-02 Tablets in Patients With Non-squamous Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutations

Role: lead

NCT07208123Not Yet Recruiting

Mechanistic Studies of Chronic COPD Using Single-Cell Sequencing and Single-Cell Spatial Transcriptomics

Role: lead

NCT07074704Not ApplicableEnrolling By Invitation

tACS to Improve Negative Symptoms & Cognition in Long-term Hospitalized Schizophrenia Patients.

Role: lead

NCT07047859Not Yet Recruiting

Clinical Investigation of Sympathetic Nerve Width Measurement in Thoracoscopic Sympathectomy

Role: lead

NCT06740188Phase 4Recruiting

Trazodone on NREM Sleep Stage Ⅲ in Depressed Insomniac Co-morbid Patients

Role: lead

NCT05669391Not ApplicableCompleted

Pharmacogenomics on Individualized Precise Treatment of Patients with Depression

Role: lead

NCT06829446Not ApplicableCompleted

Recurrent Persistent Atrial Fibrillation:In-situ Ablation Vs Extensive Ablation

Role: collaborator

NCT06775873Completed

Modified Diaphragmatic Plication Rectifies Dyspnea

Role: lead

NCT04517383Not ApplicableRecruiting

Effects of Post-Operative Sedation for Endovascular Thrombectomy

Role: collaborator

NCT06319183Early Phase 1Not Yet Recruiting

The Regulatory Function of Inhaled Asthma Medication Salbutamol on Thermogenesis

Role: lead

NCT06304350Phase 2Recruiting

Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma

Role: lead

NCT06276933Phase 4Not Yet Recruiting

A Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Role: lead

NCT05070156Early Phase 1Unknown

B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma

Role: lead

NCT05157776Phase 3Unknown

A Phase III Trial of Neoadjuvant Sintilimab and Chemotherapy for NSCLC Harboring No Driver Mutations

Role: lead